↑ トップへ ← 戻る

 Drug(薬物リスト) ALL | DrugBank 

   e.g. "Sirolimus", "アダリムマブ"    Synonyms (Drugs) were also searched for.

A B C D E F G H  I  J K L M N O P Q R S T U V W X Y Z other

70 / 12,172 descriptions found* Show info (disease name, etc.) on mouse-over.
 No.   薬物名(臨床試験情報から抽出)   DrugBank   KEGG DRUG  KEGG GENES  KEGG PATHWAY   指定難病告示番号
 1   1-(2,3,4-trimethoxybenzyl)piperazine dihydrochloride   Piperazine, piperazine dihydrochloride   D00807, D01393, D02127, D02145, D05486, D06224   -   -   1件:
58 
 2   Acetylcysteine   Acetylcysteine   D00221   -   -   14件:
6,
13,
19,
20,
49,
51,
58,
85,
94,
111,
164,
233,
298,
299 
 3   Adenosine   Adenosine   D00045   4件: ADORA1, ADORA2A, ADORA2B, ADORA3   2件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction   3件:
13,
58,
65 
 4   Alcohol   Isopropyl alcohol   D00137   -   -   4件:
13,
58,
279,
298 
 5   Antiarrhythmic drugs   -   -   -   -   1件:
58 
 6   Atorvastatin   Atorvastatin   D00258, D00887, D07474   1件: HMGCR   1件: Terpenoid backbone biosynthesis   17件:
13,
46,
49,
51,
58,
63,
79,
84,
88,
93,
96,
160,
222,
225,
265,
271,
299 
 7   Bluefish   Bluefish   -   -   -   1件:
58 
 8   Bnp blood sample test   -   -   -   -   1件:
58 
 9   Candesartan   Candesartan cilexetil   D00522, D00626   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   2件:
58,
67 
 10   Carnitine   Levocarnitine   D02030, D02176, D04713   -   -   8件:
5,
13,
58,
96,
97,
265,
298,
316 
 11   Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4- (trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4- (trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one   -   -   -   -   1件:
58 
 12   Cas name: 1,4-benzoxazepin-5(2h)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl] iupac name: 4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-3,4-dihydro-1,4-benzoxazepin-5(2h)-one   -   -   -   -   1件:
58 
 13   Ck-3773274   -   -   -   -   1件:
58 
 14   Cyclosporine   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   33件:
11,
14,
19,
20,
28,
36,
40,
41,
42,
45,
46,
49,
50,
53,
56,
58,
60,
62,
64,
65,
90,
95,
97,
162,
164,
222,
226,
228,
234,
283,
284,
285,
302 
 15   Cyclosporine a   Ciclosporin   D00184   5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2   7件: Cellular senescence, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Osteoclast differentiation, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation   8件:
19,
20,
36,
49,
53,
58,
60,
234 
 16   Diltiazem   Diltiazem   D00616, D03830, D07845   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   4件: Adrenergic signaling in cardiomyocytes, Cardiac muscle contraction, Vascular smooth muscle contraction, cAMP signaling pathway   3件:
58,
86,
130 
 17   Diovan   Valsartan   D00400   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
58 
 18   Diovan 160 mg   Valsartan   D00400   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
58 
 19   Diovan 40 mg   Valsartan   D00400   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
58 
 20   Diovan 80 mg   Valsartan   D00400   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
58 
 21   Dobutamine   Dobutamine   D00632, D03879, D03880, D03881   1件: ADRB1   6件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, cAMP signaling pathway, cGMP-PKG signaling pathway   3件:
57,
58,
215 
 22   Echo and myocardial contrast echocardiography perfusion imaging   -   -   -   -   1件:
58 
 23   Endothelial function biomarkers   -   -   -   -   1件:
58 
 24   Gadolinium   Gadolinium   -   -   -   6件:
13,
34,
46,
58,
65,
305 
 25   Gs-6615 3 mg pink   -   -   -   -   1件:
58 
 26   Gs-6615 3 mg white   -   -   -   -   1件:
58 
 27   Gs-6615 6 mg white   -   -   -   -   1件:
58 
 28   Gutron   gutron   D01307, D08220   3件: ADRA1A, ADRA1B, ADRA1D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction   1件:
58 
 29   Gutron 2,5mg   gutron   D01307, D08220   3件: ADRA1A, ADRA1B, ADRA1D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction   1件:
58 
 30   Gutron 5mg   gutron   D01307, D08220   3件: ADRA1A, ADRA1B, ADRA1D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction   1件:
58 
 31   Hyperpolarized 13c-pyruvate   pyruvate   -   -   -   1件:
58 
 32   Losartan   Losartan   D00357, D08146   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   18件:
13,
17,
19,
46,
58,
66,
67,
85,
96,
97,
98,
113,
164,
167,
179,
215,
222,
299 
 33   Losartan bluefish 50 mg   Bluefish, Losartan   D00357, D08146   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
58 
 34   Mangafodipir   Mangafodipir   D08262   -   -   2件:
13,
58 
 35   Mavacamten   Mavacamten   -   -   -   1件:
58 
 36   Mek162   -   -   -   -   2件:
58,
195 
 37   Metoprolol   Metoprolol   D00601, D02358, D05011   1件: ADRB1   2件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction   6件:
17,
57,
58,
113,
193,
226 
 38   Metoprolol succinate   Metoprolol   D00601, D02358, D05011   1件: ADRB1   2件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction   4件:
57,
58,
113,
193 
 39   Midodrine   Midodrine   D01307, D08220   3件: ADRA1A, ADRA1B, ADRA1D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction   3件:
6,
17,
58 
 40   Midodrine hydrochloride   Midodrine   D01307, D08220   3件: ADRA1A, ADRA1B, ADRA1D   4件: Calcium signaling pathway, Neuroactive ligand-receptor interaction, Salivary secretion, Vascular smooth muscle contraction   1件:
58 
 41   Monitor   Methamidophos   -   -   -   12件:
2,
11,
13,
19,
46,
49,
58,
70,
85,
98,
298,
300 
 42   Myk-461   -   -   -   -   1件:
58 
 43   N-acetylcysteine   Acetylcysteine   D00221   -   -   10件:
6,
13,
19,
20,
49,
58,
85,
111,
164,
299 
 44   Nitrate   Nitrate   D02313   -   -   3件:
58,
113,
299 
 45   Perhexiline   Perhexiline   D05442, D08340   4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S   4件: Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Cardiac muscle contraction, Vascular smooth muscle contraction   2件:
58,
272 
 46   Perxexiline   -   -   -   -   1件:
58 
 47   Pexsig   -   -   -   -   1件:
58 
 48   Piperazine   Piperazine   D00807, D01393, D02127, D02145, D05486, D06224   -   -   1件:
58 
 49   Pirfenidone   Pirfenidone   D01583   6件: CCL2, IL10, IL1A, IL1B, IL6, TNF   5件: Cellular senescence, Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, TGF-beta signaling pathway, TNF signaling pathway   10件:
34,
46,
50,
51,
58,
84,
85,
164,
222,
228 
 50   Pyruvate   pyruvate   -   -   -   2件:
58,
299 
 51   Ranexa   Ranolazine   D05700, D05701   -   -   1件:
58 
 52   Ranolazine   Ranolazine   D05700, D05701   -   -   6件:
2,
58,
86,
113,
114,
130 
 53   Ranolazine 1000 mg pr tablets   Ranolazine   D05700, D05701   -   -   1件:
58 
 54   Ranolazine 500 mg pr tablets   Ranolazine   D05700, D05701   -   -   1件:
58 
 55   Ranolazine 750 mg pr tablets   Ranolazine   D05700, D05701   -   -   1件:
58 
 56   Ranolazine pr (prolonged-release) 500 mg 1 tablet bis in die and 750 mg 1 tablet bis in die   Ranolazine   D05700, D05701   -   -   1件:
58 
 57   Regadenoson   Regadenoson   D05711   1件: ADORA2A   3件: Neuroactive ligand-receptor interaction, Vascular smooth muscle contraction, cAMP signaling pathway   1件:
58 
 58   Sacubitril   Sacubitril   D10225   1件: MME   2件: Hematopoietic cell lineage, Renin-angiotensin system   1件:
58 
 59   Sacubitril/valsartan   Sacubitril, Valsartan   D00400, D10225   2件: AGTR1, MME   5件: Adrenergic signaling in cardiomyocytes, Hematopoietic cell lineage, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   1件:
58 
 60   Sodium nitrate   Nitrate   D02313   -   -   2件:
58,
113 
 61   Spironolactone   Spironolactone   D00443   1件: NR3C2   1件: Aldosterone-regulated sodium reabsorption   6件:
58,
67,
86,
113,
218,
225 
 62   Treatment bx1514m   -   -   -   -   1件:
58 
 63   Trientine   Triethylenetetramine   -   -   -   2件:
58,
171 
 64   Trientine dihydrochloride   Triethylenetetramine, trientine dihydrochloride   -   -   -   2件:
58,
171 
 65   Trimetazidine   Trimetazidine   D01606, D08642   -   -   2件:
58,
86 
 66   Trimetazidine dihydrochloride   Trimetazidine, trimetazidine dihydrochloride   D01606, D08642   -   -   1件:
58 
 67   Trimetazidine dihydrochloride 20mg   Trimetazidine, trimetazidine dihydrochloride   D01606, D08642   -   -   1件:
58 
 68   Valsartan   Valsartan   D00400   1件: AGTR1   4件: Adrenergic signaling in cardiomyocytes, Neuroactive ligand-receptor interaction, Renin-angiotensin system, Vascular smooth muscle contraction   6件:
57,
58,
66,
75,
218,
222 
 69   Vastarel   vastarel   D01606, D08642   -   -   1件:
58 
 70   Vastarel 20mg film coated tablets   vastarel   D01606, D08642   -   -   1件:
58 

先頭へ